STI - Nursing Case Study

Pathophysiology

• Primary mechanism: Many STIs are caused by bacteria, viruses, or parasites, which enter the body through mucous membranes during sexual contact, leading to local infection and inflammation.

• Secondary mechanism: The immune response to these pathogens can cause further damage to tissues, increasing the risk of complications like pelvic inflammatory disease in women or epididymitis in men.

• Key complication: If untreated, some STIs can lead to chronic health issues, infertility, or increase the risk of acquiring other infections due to compromised mucosal barriers.

Patient Profile

Demographics:

25-year-old female, college student

History:

• Key past medical history: No significant past medical history

• Current medications: Oral contraceptive pill

• Allergies: None

Current Presentation:

• Chief complaint: Unusual vaginal discharge

• Key symptoms: Mild itching, slight discomfort during urination, no fever

• Vital signs: Blood pressure 118/76 mmHg, heart rate 72 bpm, respiratory rate 16 breaths/min, temperature 98.1°F

Section 1

Initial Assessment Findings:

Upon further examination, the patient exhibits mild erythema and swelling in the vulvar region, consistent with localized inflammation. A speculum exam reveals a thin, grayish-white discharge with a fishy odor, suggestive of bacterial vaginosis rather than a sexually transmitted infection. However, due to her chief complaint and risk factors, a full STI screening is warranted. The patient reports having two new sexual partners in the past six months, with inconsistent condom use.

During the assessment, the patient is educated on the importance of using protection during sexual encounters to prevent STIs and maintain reproductive health. A wet mount test is performed in the clinic, revealing clue cells, which further supports the initial diagnosis of bacterial vaginosis. The patient is reassured that while bacterial vaginosis is not classified as an STI, it can be associated with sexual activity and needs appropriate treatment to prevent complications such as pelvic inflammatory disease.

The patient is prescribed metronidazole, an antibiotic effective against bacterial vaginosis, and advised on completing the full course of treatment. She is also instructed to abstain from alcohol during the medication course due to potential adverse reactions. A follow-up appointment is scheduled to reassess symptoms and ensure the resolution of the discharge and other symptoms, as well as to review any pending results from the comprehensive STI panel.

Section 2

Response to Interventions:

At the follow-up appointment, the patient reports a noticeable reduction in the vulvar erythema and swelling. She also mentions that the discharge has decreased significantly and no longer has a strong odor, suggesting a positive response to the metronidazole treatment. During the physical examination, the clinician observes that the vulvar region appears less inflamed, and the discharge is minimal. This indicates that the bacterial vaginosis is resolving as expected. The patient confirms that she adhered to the medication regimen and abstained from alcohol as instructed, which likely contributed to the favorable outcome.

The comprehensive STI panel returns with all negative results, providing further reassurance to the patient. Vital signs at the follow-up visit show a stable blood pressure of 118/76 mmHg, a heart rate of 72 beats per minute, and a temperature of 98.6°F, all within normal limits. These findings, along with the patient’s improved symptoms, indicate a stable condition with no new complications at this stage.

The clinician takes this opportunity to reinforce the importance of consistent condom use to prevent future episodes of bacterial vaginosis and potential STI exposure. The patient is provided with educational materials on sexual health and encouraged to maintain regular health check-ups. With the successful resolution of symptoms and negative STI results, the patient is advised to return to the clinic if she experiences any recurrence of symptoms or new issues arise. This plan promotes ongoing health monitoring and empowers the patient to take an active role in her reproductive health.

Section 3

A few weeks after the follow-up appointment, the patient returns to the clinic for her scheduled regular health check-up. She mentions experiencing mild itching and occasional discomfort in the vulvar area over the past few days but denies any unusual discharge or odor. She expresses concern about these new symptoms and is eager to understand their cause. During the initial assessment, the nurse notes that the patient's vital signs remain stable, with a blood pressure of 116/78 mmHg, a heart rate of 74 beats per minute, and a temperature of 98.4°F. These readings suggest that her overall health status is stable.

Upon examination, the clinician observes slight erythema in the vulvar region, but no significant swelling or discharge is present. The patient’s adherence to previous recommendations, including consistent condom use, is confirmed, which lessens the likelihood of a new STI exposure. Considering the patient’s symptoms and history, the clinician decides to perform a repeat bacterial culture and sensitivity test to rule out any recurrent bacterial infection or new complication. The clinician also takes this opportunity to review the patient's hygiene practices, dietary habits, and any recent changes in personal care products that might contribute to her symptoms.

While awaiting the new diagnostic results, the clinician advises the patient to use a hypoallergenic soap and avoid any potential irritants, such as scented products or tight-fitting clothing, which could exacerbate the mild symptoms. The patient is encouraged to maintain hydration and a balanced diet to support her immune system. With the plan to follow up once the lab results are available, the patient leaves the clinic reassured and informed, actively participating in managing her health. This approach ensures that any further interventions are timely and appropriate, allowing for prompt resolution of her symptoms and continued health maintenance.

Section 4

A week later, the patient returns to the clinic for a follow-up visit to discuss the results of her diagnostic tests. The bacterial culture and sensitivity test reveal no significant growth of pathogenic bacteria, ruling out a recurrent or new bacterial infection. However, a low-level yeast presence is detected, suggesting a mild yeast infection as the probable cause of her symptoms. This finding aligns with her reported itching and occasional discomfort, as well as the erythema observed during the initial examination. The clinician discusses these results with the patient, explaining that while not uncommon, yeast infections can occur even with good hygiene and safe sexual practices.

In response to these findings, the clinician recommends a short course of antifungal medication, which is typically effective in resolving mild yeast infections. Additionally, the nurse provides education on preventive measures, emphasizing the importance of maintaining a dry and breathable environment in the vulvar area, which can help prevent future occurrences. The patient is advised to continue using hypoallergenic products and to report any persistent or worsening symptoms promptly.

The patient expresses relief at having a clear diagnosis and a straightforward treatment plan. As she prepares to leave the clinic, she is reminded of the importance of completing the full course of prescribed medication, even if symptoms improve quickly. The nurse schedules a follow-up appointment to ensure the resolution of symptoms and to reassess her overall health status, further empowering the patient to take an active role in her health management. This approach not only addresses her current condition but also reinforces foundational concepts of patient education and preventive care.

Section 5

A few days after starting the antifungal medication, the patient calls the clinic to report that her symptoms have improved significantly, with the itching and discomfort nearly resolved. However, she mentions experiencing a mild increase in vaginal discharge, which is clear and odorless. The nurse reassures the patient that a slight increase in discharge can be a normal response as the infection clears up, but advises her to monitor the symptom to ensure it does not worsen or change in character.

During the follow-up appointment scheduled a week later, the nurse conducts a thorough assessment. The patient's vital signs are stable: temperature 98.6°F, pulse 72 bpm, respiratory rate 16 breaths per minute, and blood pressure 118/76 mmHg. Upon examination, the erythema previously observed has resolved, and there are no signs of new lesions or irritation in the vulvar area. The patient reports feeling well overall, with no significant discomfort. A repeat pelvic exam confirms the improvement, with no signs of inflammation or significant yeast presence.

The nurse reviews the importance of completing the antifungal medication regimen, even though symptoms have improved, to ensure the infection is fully resolved. The patient is encouraged to maintain her preventive measures, such as wearing breathable cotton underwear and avoiding tight-fitting clothing. As the patient leaves the clinic, the nurse schedules another follow-up in a month to reassess the patient's health and reinforce the importance of ongoing preventive care, ensuring the patient feels supported in managing her health proactively. This continuity of care helps reinforce the education provided and empowers the patient to maintain her well-being.